These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 10612671

  • 1. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.
    Garrett E, Miller AR, Goldman JM, Apperley JF, Melo JV.
    Virology; 2000 Jan 05; 266(1):170-9. PubMed ID: 10612671
    [Abstract] [Full Text] [Related]

  • 2. Replication-competent retrovirus produced by a 'split-function' third generation amphotropic packaging cell line.
    Chong H, Vile RG.
    Gene Ther; 1996 Jul 05; 3(7):624-9. PubMed ID: 8818650
    [Abstract] [Full Text] [Related]

  • 3. Construction and use of a safe and efficient amphotropic packaging cell line.
    Markowitz D, Goff S, Bank A.
    Virology; 1988 Dec 05; 167(2):400-6. PubMed ID: 2462307
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Characterization of a replication-competent retrovirus resulting from recombination of packaging and vector sequences.
    Otto E, Jones-Trower A, Vanin EF, Stambaugh K, Mueller SN, Anderson WF, McGarrity GJ.
    Hum Gene Ther; 1994 May 05; 5(5):567-75. PubMed ID: 8054374
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pathogenesis of replication competent retroviruses derived from mouse cells in immunosuppressed primates: implications for use of neoplastic cells as vaccine substrates.
    Purcell DF.
    Dev Biol (Basel); 2001 May 05; 106():187-98; discussion 199, 253-63. PubMed ID: 11761231
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An improved method for detection of replication-competent retrovirus in retrovirus vector products.
    Uchida E, Sato K, Iwata A, Ishii-Watabe A, Mizuguchi H, Hikata M, Murata M, Yamaguchi T, Hayakawa T.
    Biologicals; 2004 Sep 05; 32(3):139-46. PubMed ID: 15536044
    [Abstract] [Full Text] [Related]

  • 14. Construction of new retroviral producer cells from adenoviral and retroviral vectors.
    Lin X.
    Gene Ther; 1998 Sep 05; 5(9):1251-8. PubMed ID: 9930327
    [Abstract] [Full Text] [Related]

  • 15. Generation of retroviral packaging and producer cell lines for large-scale vector production with improved safety and titer.
    Dubensky TW, Sauter SL.
    Methods Mol Med; 2003 Sep 05; 76():309-30. PubMed ID: 12526171
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Retroviral gene transfer using safe and efficient packaging cell lines.
    Markowitz D, Hesdorffer C, Ward M, Goff S, Bank A.
    Ann N Y Acad Sci; 1990 Sep 05; 612():407-14. PubMed ID: 2291567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.